scispace - formally typeset
J

Justin A. Bishop

Researcher at University of Texas Southwestern Medical Center

Publications -  366
Citations -  20099

Justin A. Bishop is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Medicine & Carcinoma. The author has an hindex of 55, co-authored 327 publications receiving 15411 citations. Previous affiliations of Justin A. Bishop include Johns Hopkins University School of Medicine & University of Virginia.

Papers
More filters
Journal ArticleDOI

Comprehensive genomic characterization of head and neck squamous cell carcinomas

Michael S. Lawrence, +309 more
- 29 Jan 2015 - 
TL;DR: It is shown that human-papillomavirus-associated tumours are dominated by helical domain mutations of the oncogene PIK3CA, novel alterations involving loss of TRAF3, and amplification of the cell cycle gene E2F1.
Journal ArticleDOI

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal, +242 more
- 23 Oct 2014 - 
TL;DR: The genomic landscape of 496 PTCs is described and a reclassification of thyroid cancers into molecular subtypes that better reflect their underlying signaling and differentiation properties is proposed, which has the potential to improve their pathological classification and better inform the management of the disease.
Journal ArticleDOI

Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma

TL;DR: The role of the PD-1:PD-L1 interaction in creating an "immune-privileged" site for initial viral infection and subsequent adaptive immune resistance once tumors are established is supported and a rationale for therapeutic blockade of this pathway is suggested in patients with HPV-HNSCC.
Journal ArticleDOI

BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

TL;DR: Coexisting BRAF V600E and TERT C228T mutations form a novel genetic background that defines PTC with the worst clinicopathologic outcomes, providing unique prognostic and therapeutic implications.
Journal ArticleDOI

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

TL;DR: For the first time, to the authors' knowledge, TERT promoter mutations in thyroid cancers are demonstrated, that are particularly prevalent in the aggressive thyroid cancers TCPTC, PDTC, ATC and BRAF mutation-positive PTC, revealing a novel genetic background for thyroid cancers.